The Ala/Va198 polymorphism of the hepatocyte nuclear factor-1α gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: Evidence from studies of 231 glucose- tolerant first degree relatives of type 2 diabetic probands

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4506-4509

  Urhammer, Søren A ^a   Hansen, Torben ^a   Ekstrøm, Claus T ^a   Eiberg, Hans ^b   Pedersen, Oluf ^a  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; NUCLEAR FACTOR I; DNA BINDING PROTEIN; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; NUCLEAR PROTEIN; TCF1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CAUCASIAN; CHILD; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; MALE; MATURITY ONSET DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ADULT; AMINO ACID SEQUENCE; BLOOD; DIABETES MELLITUS; GENETICS; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AMINO ACID SEQUENCE; C-PEPTIDE; DIABETES MELLITUS; DNA-BINDING PROTEINS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0032217152     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.12.5359     Document Type: Article

References (19)

1. 1. Yamagata K, Furuta H, Oda N, et al. 1996 Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature. 384:458-460.
2. 2. Vionnet N, Stoffel M, Takeda J, et al. 1992 Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature. 356:721-722.
3. 3. Yamagata K, Oda N, Kaisaki PJ, et al. 1996 Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384:455-458.
4. 4. Stoffers DA, Ferrer J, Clarke WL, Habener JF. 1997 Early-onset type-2 diabetes-mellitus (MODY4) linked to ipf1. Nat Genet. 17:138-139.
5. 5. Horikawa Y, Iwasaki N, Hara M, et al. 1997 Mutation in hepatocyte nuclear factor-1-beta gene (TCF2) associated with MODY. Nat Genet. 17:384-385.
6. 6. Hattersley AT. 1998 Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabetic Med. 15:15-24.
7. 7. Hansen T, Eiberg H, Rouard M, et al. 1997 Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes. 46:726-730.
8. 8. Mahtani MM, Widen E, Lehto M, et al. 1996 Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet. 14:90-94.
9. 9. Bowden DW, Sale M, Howard TD, et al. 1997 Linkage of genetic-markers on human-chromosome-20 and human-chromosome-12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes. 46:882-886.
10. 10. Urhammer SA, Rasmussen SK, Kaisaki PJ, et al. 1997 Genetic variation in the hepatocyte nuclear factor-1α gene in Danish Caucasians with late-onset NIDDM. Diabetologia. 40:473-475.
11. 11. Urhammer SA, Fridberg M, Hansen T, et al. 1997 A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1α gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes. 46:912-916.
12. 12. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. 1993 Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 39:578-582.
13. 13. Heding LG. 1977 Specific and direct radioimmunoassay for human proinsulin in serum. Diabetologia. 13:467-474.
14. 14. Faber OK, Binder C, Markussen J, et al. 1978 Characterization of seven C-peptide antisera. Diabetes. 27(Suppl 1):170-177.
15. 15. Faber OK, Markussen J, Naithani VK, Binder C. 1976 Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe-Seylers Z Physiol Chem. 357:751-757.
16. 16. Hopper JL, Mathews JD. 1982 Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet. 46:373-383.
17. 17. Polonsky KS. 1995 Lilly lecture 1994. The β-cell in diabetes: from molecular genetics to clinical research. Diabetes. 44:705-717.
18. 18. Cereghini S. 1996 Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10:267-282.
19. 19. Horlein A, Grajer KH, Igokemenes T. 1993 Genomic structure of the pourelated hepatic transcription factor HNF-1alpha. Biol Chem Hoppe-Seyler. 374:419-425.